通过扩散和细胞骨架依赖机制的蛋白质体的压力诱导的重组
Michael J Morten1, Yu Zhang2, Bing Li2
1Department of Brain Sciences, Imperial College London, 86 Wood Lane, London, W12 0BZ, UK.
Small (Weinheim an der Bergstrasse, Germany)
|November 24, 2025
概括
在蛋白质毒性压力下,蛋白质体重组成焦点体,称为暂时聚合物相关滴 (TAADs). 这种重组依赖于细胞骨,并与细胞脱极化有关,限制了蛋白质体运动.
科学领域:
- 细胞生物学 细胞生物学
- 分子生物学分子生物学
- 生物物理学的生物物理.
背景情况:
- 蛋白质体对于真核细胞中的蛋白质降解至关重要.
- 它们在响应细胞需求时的动态定位正在调查中.
- 阿尔法-同核素聚合物诱导蛋白质毒性压力,导致蛋白质体重组.
研究的目的:
- 在蛋白质毒性压力下研究蛋白质酶体重组和暂时聚合物相关滴滴 (TAAD) 形成.
- 阐明控制蛋白酶体动力学和局部化的机制.
- 了解细胞骨和细胞膜潜力的作用在蛋白质体重组中的作用.
主要方法:
- 单分子局部化显微镜.
- 光片显微镜的使用方法
- 聚合物的纳米管子注射.
- 一个单细胞补丁紧.
- 单颗粒追踪系统是一个单颗粒追踪系统.
主要成果:
- 蛋白质体密度的再分配发生在对α-synuclein聚合物的反应中.
- 在应力过程中,20S核心粒子与19S调节粒子的比率保持不变.
- TAAD的形成依赖于细胞骨,并与细胞脱极化有关.
- 蛋白质体表现出明显的运动模式,在压力下被限制在TAAD中.
结论:
- 蛋白酶体重组是在蛋白质毒性压力期间严格规范的过程.
- 细胞骨和细胞膜潜力直接影响蛋白质酶体的局部化.
- 蛋白酶体运动在TAADs内受到限制,从而促进选择性蛋白质静止.
更多相关视频
10:24Defining Hsp33's Redox-regulated Chaperone Activity and Mapping Conformational Changes on Hsp33 Using Hydrogen-deuterium Exchange Mass Spectrometry
Published on: June 7, 2018
9.1K
09:57Examining Proteasome Assembly with Recombinant Archaeal Proteasomes and Nondenaturing PAGE: The Case for a Combined Approach
Published on: December 17, 2016
7.0K
相关概念视频
The Proteasome
1.6K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.6K
The Proteasome
10.0K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.0K
The Proteasome
4.4K
4.4K
The Proteasome Structure
1.6K
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
The proteasome is an...
1.6K
Destabilization of Microtubules
3.4K
The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
3.4K
The Unfolded Protein Response
6.2K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
6.2K
